ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 44 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91,969 | -15.7% | 117,909 | 0.0% | 0.00% | – |
| Q2 2023 | $109,065 | -5.5% | 117,909 | +11.3% | 0.00% | – |
| Q1 2023 | $115,441 | +74861.7% | 105,910 | 0.0% | 0.00% | – |
| Q4 2022 | $154 | -99.8% | 105,910 | +45.5% | 0.00% | – |
| Q3 2022 | $78,000 | -36.6% | 72,769 | 0.0% | 0.00% | – |
| Q2 2022 | $123,000 | -17.4% | 72,769 | 0.0% | 0.00% | – |
| Q1 2022 | $149,000 | -45.2% | 72,769 | 0.0% | 0.00% | – |
| Q4 2021 | $272,000 | -27.7% | 72,769 | 0.0% | 0.00% | – |
| Q3 2021 | $376,000 | +21.7% | 72,769 | 0.0% | 0.00% | – |
| Q2 2021 | $309,000 | -19.9% | 72,769 | 0.0% | 0.00% | – |
| Q1 2021 | $386,000 | +45.7% | 72,769 | +47.9% | 0.00% | – |
| Q4 2020 | $265,000 | -70.0% | 49,188 | -55.5% | 0.00% | – |
| Q3 2020 | $883,000 | +44.8% | 110,655 | +81.5% | 0.00% | – |
| Q2 2020 | $610,000 | +338.8% | 60,952 | +18.6% | 0.00% | – |
| Q1 2020 | $139,000 | -40.6% | 51,389 | -73.8% | 0.00% | – |
| Q4 2019 | $234,000 | +143.8% | 196,014 | +206.3% | 0.00% | – |
| Q3 2019 | $96,000 | -62.6% | 64,000 | 0.0% | 0.00% | – |
| Q2 2019 | $257,000 | -6.5% | 64,000 | 0.0% | 0.00% | – |
| Q1 2019 | $275,000 | -38.9% | 64,000 | -18.5% | 0.00% | – |
| Q4 2018 | $450,000 | -16.2% | 78,496 | +97.9% | 0.00% | – |
| Q3 2018 | $537,000 | +10.3% | 39,655 | -3.6% | 0.00% | – |
| Q2 2018 | $487,000 | +0.4% | 41,137 | -4.8% | 0.00% | – |
| Q1 2018 | $485,000 | +153.9% | 43,211 | +50.7% | 0.00% | – |
| Q4 2017 | $191,000 | -18.4% | 28,667 | +0.2% | 0.00% | – |
| Q3 2017 | $234,000 | +82.8% | 28,605 | 0.0% | 0.00% | – |
| Q2 2017 | $128,000 | +39.1% | 28,605 | +69.9% | 0.00% | – |
| Q1 2017 | $92,000 | +39.4% | 16,841 | +2.6% | 0.00% | – |
| Q4 2016 | $66,000 | -41.6% | 16,421 | +1.7% | 0.00% | – |
| Q3 2016 | $113,000 | +36.1% | 16,141 | +57.1% | 0.00% | – |
| Q2 2016 | $83,000 | – | 10,273 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |